Blog

What NDB Rupee Bond Means for Investors, India, and BRICS

NDB plans its first rupee-denominated bond by March 2026. Here’s why this move matters for India, BRICS, and the global financial system. Imagine this: you’re sitting in Mumbai traffic, scrolling through financial news on your phone. Suddenly, you read that the New Development Bank (NDB) — a bank backed by BRICS nations — is preparing […]

Blog

“Saatvik Green Energy IPO: Flat Debut, Bright Future?”

Saatvik Green Energy IPO debuts flat at ₹465, but strong fundamentals, expansion plans, and solar growth potential make it a stock worth tracking. Imagine waiting weeks for your favorite cricket match, only for the first over to end with dot balls. No sixes, no fours — just calm, steady play. That’s exactly how the Saatvik

Blog

IBPS PO Prelims Result 2025 Out: Direct Link & Cut Off Trends

IBPS PO Prelims Result 2025 out! Check direct link, cut off, scorecard details, and what’s next for the October 12 mains exam. If you’ve appeared for the IBPS PO Prelims 2025, chances are you’ve been refreshing the official website every few hours, waiting for the results. The anxiety is real — because this exam isn’t

Blog

Why TCS Share Price is Falling: Real Reasons Behind the Decline

Why is TCS share price falling? Explore the real reasons behind TCS’s decline, from FII selling to sector weakness, and what it means for investors. If you’ve been tracking the stock market lately, one question might be nagging you: Why is TCS share price falling so sharply despite being India’s most trusted IT giant? For

Blog

Accenture Layoffs 2025: The Harsh Truth Behind AI Restructuring

Accenture layoffs 2025: Over 11,000 employees let go amid AI restructuring. Explore reasons, impact, and what it means for India’s IT future. Imagine this: You’ve worked for years at one of the biggest IT consulting firms in the world. Suddenly, one morning, you receive an email saying your role no longer exists. Why? Because artificial

Blog

“Sun Pharma, Cipla, and Dr. Reddy’s Under the Tariff Lens: Expert Insights”

Explore how Trump’s 100% pharma tariff affects Indian pharmaceutical companies like Sun Pharma, Cipla, and Dr. Reddy’s, with key insights for investors. Imagine you’re running a business where nearly half your revenue comes from one foreign market, and suddenly, overnight, a 100% tax is slapped on your products. That’s exactly the situation Indian pharmaceutical companies

Scroll to Top